MedTrace Logo

A Prospective Study of Application of Platelet Mapping in HBV-related Acute-on-chronic-liver Failure in China

NCT03281278 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2019-06-06

No results posted yet for this study

Summary

Ineffective hemostasis or a paradoxical prothrombotic state of Acute-on-chronic liver disease (ACLF) has been well established. Thrombelastography measures the dynamics of thrombin production and provides a global assessment of coagulation incorporating the cumulative effect of the interactions at various levels between plasma components and cellular component of coagulation. And through the platelet mapping, it can help provide a picture of patients' function of platelet. This study aims to explore the predictive role of platelet mapping in ACLF prognosis, organ failure developments and short term mortality.

Conditions

  • Thrombelastography,Acute on Chronic Liver Failure, Platelet

Interventions

OTHER

standard treatment

standard medical treatment

Sponsors & Collaborators

  • Nanfang Hospital, Southern Medical University

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-10-30
Primary Completion
2018-08-13
Completion
2018-08-13

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03281278 on ClinicalTrials.gov